Long‐term data from a phase 3 study of radotinib versus imatinib in patients with newly diagnosed, chronic myeloid leukaemia in the chronic phase (RERISE)

Author:

Do Young Rok1,Kwak Jae‐Yong2,Kim Jeong A.3,Kim Hyeoung Joon4,Chung Joo Seop5,Shin Ho‐Jin5,Kim Sung‐Hyun6,Bunworasate Udomsak7,Choi Chul Won8,Zang Dae Young9,Oh Suk Joong10,Jootar Saengsuree11,Reksodiputro Ary Harryanto12,Lee Won Sik13,Mun Yeung‐Chul14,Kong Jee Hyun15,Caguioa Priscilla B.16,Kim Hawk17ORCID,Park Jinny17,Kim Dong‐Wook18ORCID

Affiliation:

1. Dongsan Medical Center Keimyung University Daegu South Korea

2. Chonbuk National University Medical School & Hospital Jeonju South Korea

3. St. Vincent Hospital The Catholic University of Korea Suwon South Korea

4. Chonnam National University Hwasun Hospital Hwasun South Korea

5. Pusan National University Hospital Busan South Korea

6. Dong‐A University Medical Center Busan South Korea

7. King Chulalongkorn Memorial Hospital Chulalongkorn University Bangkok Thailand

8. Korea University Guro Hospital Seoul South Korea

9. Hallym University Sacred Heart Hospital Anyang South Korea

10. Kangbuk Samsung Hospital Sungkyunkwan University School of Medicine Seoul South Korea

11. Faculty of Medicine Ramathibodi Hospital Mahidol University Bangkok Thailand

12. Rumah Sakit Dr Cipto Mangunkusumo Hospital Jakarta Indonesia

13. Inje University Busan Paik Hospital Busan South Korea

14. Ewha Womans University College of Medicine Seoul South Korea

15. Wonju Severance Christian Hospital Wonju South Korea

16. St. Luke’s Medical Center Quezon Philippines

17. Gachon University Gil Medical Center Gachon University College of Medicine Incheon South Korea

18. Seoul St. Mary's Hematology Hospital, Leukemia Research Institute The Catholic University of Korea Seoul South Korea

Funder

IL-YANG PHARM. Co., Ltd

Publisher

Wiley

Subject

Hematology

Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3